KK Shah Hospitals FY26 Results: Net loss widens to ₹62.27 lakh

kk shah hospitals reported a widening net loss of ₹62.27 lakh for FY26, up from ₹32.72 lakh in FY25, as total expenses outpaced revenue growth. While income from operations rose 4.8% to ₹942.76 lakh, total expenses increased to ₹1,034.55 lakh from ₹988.04 lakh. The divergence between top-line growth and bottom-line deterioration signals margin pressure amid significant capital investments in infrastructure and technology.

The company’s fourth annual general meeting is scheduled for August 18, 2026, at its registered office in Ratlam, Madhya Pradesh. Ordinary business includes the adoption of audited financial statements and the re-appointment of Dr. Milli Shah, who retires by rotation. A special resolution seeks shareholder approval for director remuneration exceeding the overall managerial limit of 11% of net profits under Section 197 of the Companies Act, 2013.

Financial Performance

Revenue from operations grew to ₹942.76 lakh from ₹899.86 lakh in FY25. However, other income declined sharply to ₹18.94 lakh from ₹55.54 lakh, reducing total revenue growth to just 0.7%. Total expenses rose by ₹46.51 lakh year-on-year, primarily due to higher employee benefit expenses (₹268.95 lakh vs ₹254.23 lakh) and depreciation charges (₹168.37 lakh vs ₹101.27 lakh). Profit before tax stood at a loss of ₹72.84 lakh, compared to ₹32.64 lakh in the prior year.

Metric	FY26 (₹ lakh)	FY25 (₹ lakh)	Change
Income from Operations	942.76	899.86	+4.8%
Other Income	18.94	55.54	-65.9%
Total Expenses	1,034.55	988.04	+4.7%
Net Loss	62.27	32.72	Widened

Strategic Investments and Operations

Management highlighted several infrastructure upgrades aimed at long-term growth. The company commissioned a new 65-bed hospital facility in Thandla and installed advanced diagnostic equipment, including a CT Scan machine and a Siemens Magnetom Essenza 1.5T MRI Scanner. Additionally, robotic technology was introduced to enhance surgical precision. These capital expenditures contributed to the higher depreciation charge and capital work-in-progress of ₹622.44 lakh as of March 31, 2026.

What the Numbers Show

The operating profit margin improved significantly to 8.12% from 1.45% in FY25, indicating better core operational efficiency. However, this gain was offset by a sharp decline in other income, which fell by ₹36.6 lakh. The net profit margin deteriorated to -6.61% from -3.64%, reflecting the impact of higher fixed costs and depreciation relative to revenue. Trade receivables turnover ratio doubled to 32.22 times from 15.33 times, suggesting faster collection cycles or a change in credit terms.

Governance and Compliance

M/s A Y & Company served as statutory auditors, issuing an unqualified report. M/s Dilip Swarnkar & Associates conducted the secretarial audit, noting no material non-compliances. The board recommended the special resolution for director remuneration, citing the need to retain key management personnel. Interested directors, including Amit Shah, Kirti Kumar Shah, Hansa Shah, and Milli Shah, will abstain from voting on this resolution.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	+0.93%	-2.94%	+2.61%	-0.15%	-33.80%

kk shah hospitals reported a net loss of ₹62.27 lakh for the financial year ended March 31, 2026 (FY26), widening significantly from a net loss of ₹32.72 lakh in FY25. The company’s 4th Annual General Meeting (AGM) is scheduled for August 18, 2026, at its registered office in Ratlam, Madhya Pradesh, where shareholders will approve the audited financial statements and seek consent for director remuneration exceeding statutory limits under Section 197 of the Companies Act, 2013.

Despite the increased loss, revenue from operations grew 4.8% year-on-year to ₹942.76 lakh, up from ₹899.86 lakh in FY25. Total income stood at ₹961.71 lakh, supported by other income of ₹18.94 lakh. However, total expenses rose to ₹1,034.55 lakh from ₹988.04 lakh in the prior year, leading to a profit before tax deficit of ₹72.84 lakh. After accounting for a deferred tax charge of ₹10.57 lakh, the final net loss reached ₹62.27 lakh.

Financial Performance Snapshot

Metric	FY26 (₹ Lakh)	FY25 (₹ Lakh)	Change
Revenue from Operations	942.76	899.86	+4.8%
Other Income	18.94	55.54	-65.9%
Total Expenses	1,034.55	988.04	+4.7%
Profit Before Tax	-72.84	-32.64	Wider Loss
Net Profit After Tax	-62.27	-32.72	Wider Loss

The Board decided against declaring any dividend for FY26 due to the incurred losses. Reserves and surplus declined to ₹598.47 lakh from ₹660.74 lakh in the previous year. The company’s authorized capital remains at ₹7.50 crore, with paid-up capital of ₹6.81 crore.

Operational Developments

Management highlighted strategic infrastructure expansions as key drivers for future growth. During FY26, the company commissioned a new 65-bed hospital facility in Thandla, aiming to improve regional healthcare accessibility. Diagnostic capabilities were enhanced through the installation of an advanced CT Scan machine and the commencement of installation for a Siemens Magnetom Essenza 1.5T MRI Scanner. Additionally, the company introduced robotic technology for surgical procedures and expanded its Outpatient Departments (OPDs) to manage increasing patient inflow.

What the Numbers Show

A critical divergence exists between operating revenue growth and profitability metrics. While revenue from operations increased by nearly 5%, other income collapsed by 66%, falling from ₹55.54 lakh to ₹18.94 lakh. This sharp decline in non-operating income, combined with a 4.7% rise in total expenses, underscores that the widening loss is driven by both reduced ancillary earnings and rising operational costs. Employee benefit expenses rose to ₹268.95 lakh from ₹254.23 lakh, while depreciation charges more than doubled to ₹168.37 lakh from ₹101.27 lakh, reflecting significant capital investments in new assets that have yet to translate into proportional revenue gains.

Governance and Compliance

The AGM agenda includes the re-appointment of Dr. Milli Shah as Executive Director, who retires by rotation. Shareholders will also vote on a special resolution to approve remuneration for directors exceeding the overall managerial limit of 11% of net profits, as permitted under Section 197 read with Schedule V of the Companies Act, 2013. M/s A Y & Company served as statutory auditors, issuing an unqualified report, while M/s Dilip Swarnkar & Associates conducted the secretarial audit with no adverse remarks.